FREE CME/CNE Activity - FOR MEDICAL PROFESSIONALS ONLY
Management Problems in Systemic Sclerosis will be offered on Saturday, March 5,
Francisco Airport Marriott Waterfront
1800 Old Bayshore Highway, Burlingame, CA 94010
Scleroderma Foundation and the Postgraduate Institute for Medicine is
hosting a FREE CME/CNE Activity on Saturday, March 5, 2016 in San Francisco; The general objective of this event will be to raise
awareness about difficult management problems in systemic sclerosis
related to gastrointestinal involvement, Raynaud phenomenon, and digital ulcers. Pre-registration is required.
University of Utah Doctor Leads Trial of New Systemic Sclerosis Drug
doctors worldwide are testing a new drug to treat systemic sclerosis
including Dr. Tracy Frech at the University of Utah. Dr. Frech helped
start the systemic sclerosis clinic at the University of Utah, which
remains the only one in the Intermountain West.
Scholarship Applications Now Being Accepted for 2016 Conference
first time attendees, the National Conference brings hope to those who
thought they were alone in the fight against scleroderma. Thanks to the
generous support of many donors and chapters, conference scholarships
will be available to the 2016 National Patient Education Conference in
New Orleans, LA, from July 29-31, 2016.
According to the National Institutes of Health, people who practiced yoga or took natural products were more likely to do so for wellness reasons than to treat a specific health condition. More than 80 percent of yoga users reported reduced stress as a resulting of practicing yoga.
Are you new to yoga and not sure where to start? Thanks to our friend Kathy Randolph you can start your yoga practice at home. Kathy has released a therapeutic program of yoga poses and breathing techniques selected for scleroderma patients.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.